152 related articles for article (PubMed ID: 29156222)
1. Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
Stefaniak JD; Su L; Mak E; Sheikh-Bahaei N; Wells K; Ritchie K; Waldman A; Ritchie CW; O'Brien JT
Alzheimers Dement; 2018 Feb; 14(2):253-258. PubMed ID: 29156222
[TBL] [Abstract][Full Text] [Related]
2. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
[TBL] [Abstract][Full Text] [Related]
3. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
Low A; Su L; Stefaniak JD; Mak E; Dounavi ME; Muniz-Terrera G; Ritchie K; Ritchie CW; Markus HS; O'Brien JT
Neurobiol Aging; 2021 Feb; 98():124-133. PubMed ID: 33264710
[TBL] [Abstract][Full Text] [Related]
4. Association of common genetic variants with brain microbleeds: A genome-wide association study.
Knol MJ; Lu D; Traylor M; Adams HHH; Romero JRJ; Smith AV; Fornage M; Hofer E; Liu J; Hostettler IC; Luciano M; Trompet S; Giese AK; Hilal S; van den Akker EB; Vojinovic D; Li S; Sigurdsson S; van der Lee SJ; Jack CR; Wilson D; Yilmaz P; Satizabal CL; Liewald DCM; van der Grond J; Chen C; Saba Y; van der Lugt A; Bastin ME; Windham BG; Cheng CY; Pirpamer L; Kantarci K; Himali JJ; Yang Q; Morris Z; Beiser AS; Tozer DJ; Vernooij MW; Amin N; Beekman M; Koh JY; Stott DJ; Houlden H; Schmidt R; Gottesman RF; MacKinnon AD; DeCarli C; Gudnason V; Deary IJ; van Duijn CM; Slagboom PE; Wong TY; Rost NS; Jukema JW; Mosley TH; Werring DJ; Schmidt H; Wardlaw JM; Ikram MA; Seshadri S; Launer LJ; Markus HS;
Neurology; 2020 Dec; 95(24):e3331-e3343. PubMed ID: 32913026
[TBL] [Abstract][Full Text] [Related]
5. Effect of Low-Dose Statins and Apolipoprotein E Genotype on Cerebral Small Vessel Disease in Older Hypertensive Patients: A Subgroup Analysis of a Randomized Clinical Trial.
Ji T; Zhao Y; Wang J; Cui Y; Duan D; Chai Q; Zhang H; Liu Z
J Am Med Dir Assoc; 2018 Nov; 19(11):995-1002.e4. PubMed ID: 30006015
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Tranfa M; Lorenzini L; Collij LE; Vállez García D; Ingala S; Pontillo G; Pieperhoff L; Maranzano A; Wolz R; Haller S; Blennow K; Frisoni G; Sudre CH; Chételat G; Ewers M; Payoux P; Waldman A; Martinez-Lage P; Schwarz AJ; Ritchie CW; Wardlaw JM; Gispert JD; Brunetti A; Mutsaerts HJMM; Wink AM; Barkhof F
Ann Clin Transl Neurol; 2024 Jun; 11(6):1541-1556. PubMed ID: 38757392
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
[TBL] [Abstract][Full Text] [Related]
8. DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease.
Sala-Vila A; Arenaza-Urquijo EM; Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Grau-Rivera O; González-de-Echávarri JM; Crous-Bou M; Minguillón C; Fauria K; Operto G; Falcón C; Salvadó G; Cacciaglia R; Ingala S; Barkhof F; Schröder H; Scarmeas N; Gispert JD; Molinuevo JL;
Am J Clin Nutr; 2021 Jun; 113(6):1627-1635. PubMed ID: 33733657
[TBL] [Abstract][Full Text] [Related]
9. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
[TBL] [Abstract][Full Text] [Related]
10. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes.
Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD;
Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545
[TBL] [Abstract][Full Text] [Related]
11. Associations of Vascular Risk Factors and
Laveskog A; Wang R; Vetrano DL; Bronge L; Wahlund LO; Qiu C
J Am Heart Assoc; 2020 Aug; 9(16):e015229. PubMed ID: 32805190
[TBL] [Abstract][Full Text] [Related]
12. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
[TBL] [Abstract][Full Text] [Related]
13. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
14. The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals.
Ingala S; Mazzai L; Sudre CH; Salvadó G; Brugulat-Serrat A; Wottschel V; Falcon C; Operto G; Tijms B; Gispert JD; Molinuevo JL; Barkhof F;
Neurobiol Aging; 2020 Nov; 95():104-114. PubMed ID: 32791423
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
16. Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease.
Stamm BC; Lao PJ; Rizvi B; Colon J; Igwe K; Chesebro AG; Maas B; Schupf N; Mayeux R; Manly JJ; Brickman AM
J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2156-2161. PubMed ID: 31838489
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.
van Sloten TT; Sigurdsson S; van Buchem MA; Phillips CL; Jonsson PV; Ding J; Schram MT; Harris TB; Gudnason V; Launer LJ
Am J Psychiatry; 2015 Jun; 172(6):570-8. PubMed ID: 25734354
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.
Lemmens R; Görner A; Schrooten M; Thijs V
Stroke; 2007 Apr; 38(4):1185-8. PubMed ID: 17322072
[TBL] [Abstract][Full Text] [Related]
19. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
20.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
